Controversies in Dermatology
Primary Cutaneous CD30+ Lymphoproliferative Disorders
Síndrome linfoproliferativo CD30+ cutáneo primario
Read
8109
Timeswas read the article
3297
Total PDF
4812
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 72 | 26 | 98 |
| 2025 5 | 117 | 34 | 151 |
| 2025 4 | 134 | 34 | 168 |
| 2025 3 | 99 | 32 | 131 |
| 2025 2 | 96 | 47 | 143 |
| 2025 1 | 79 | 35 | 114 |
| 2024 12 | 70 | 18 | 88 |
| 2024 11 | 78 | 59 | 137 |
| 2024 10 | 65 | 54 | 119 |
| 2024 9 | 59 | 27 | 86 |
| 2024 8 | 85 | 61 | 146 |
| 2024 7 | 66 | 34 | 100 |
| 2024 6 | 72 | 44 | 116 |
| 2024 5 | 52 | 39 | 91 |
| 2024 4 | 55 | 31 | 86 |
| 2024 3 | 47 | 34 | 81 |
| 2024 2 | 56 | 41 | 97 |
| 2024 1 | 45 | 42 | 87 |
| 2023 12 | 53 | 36 | 89 |
| 2023 11 | 45 | 26 | 71 |
| 2023 10 | 46 | 30 | 76 |
| 2023 9 | 47 | 27 | 74 |
| 2023 8 | 23 | 25 | 48 |
| 2023 7 | 36 | 57 | 93 |
| 2023 6 | 49 | 28 | 77 |
| 2023 5 | 45 | 36 | 81 |
| 2023 4 | 46 | 24 | 70 |
| 2023 3 | 29 | 38 | 67 |
| 2023 2 | 33 | 28 | 61 |
| 2023 1 | 30 | 34 | 64 |
| 2022 12 | 38 | 42 | 80 |
| 2022 11 | 13 | 27 | 40 |
| 2022 10 | 26 | 19 | 45 |
| 2022 9 | 25 | 36 | 61 |
| 2022 8 | 21 | 42 | 63 |
| 2022 7 | 15 | 38 | 53 |
| 2022 6 | 15 | 21 | 36 |
| 2022 5 | 28 | 46 | 74 |
| 2022 4 | 32 | 36 | 68 |
| 2022 3 | 43 | 68 | 111 |
| 2022 2 | 27 | 40 | 67 |
| 2022 1 | 24 | 40 | 64 |
| 2021 12 | 27 | 47 | 74 |
| 2021 11 | 29 | 51 | 80 |
| 2021 10 | 32 | 52 | 84 |
| 2021 9 | 25 | 48 | 73 |
| 2021 8 | 19 | 51 | 70 |
| 2021 7 | 13 | 33 | 46 |
| 2021 6 | 45 | 48 | 93 |
| 2021 5 | 29 | 38 | 67 |
| 2021 4 | 80 | 31 | 111 |
| 2021 3 | 83 | 27 | 110 |
| 2021 2 | 56 | 33 | 89 |
| 2021 1 | 25 | 17 | 42 |
| 2020 12 | 39 | 16 | 55 |
| 2020 11 | 24 | 19 | 43 |
| 2020 10 | 34 | 15 | 49 |
| 2020 9 | 29 | 10 | 39 |
| 2020 8 | 27 | 31 | 58 |
| 2020 7 | 23 | 23 | 46 |
| 2020 6 | 29 | 25 | 54 |
| 2020 5 | 31 | 26 | 57 |
| 2020 4 | 25 | 24 | 49 |
| 2020 3 | 29 | 31 | 60 |
| 2020 2 | 3 | 7 | 10 |
| 2020 1 | 0 | 17 | 17 |
| 2019 12 | 0 | 13 | 13 |
| 2019 11 | 0 | 1 | 1 |
| 2019 10 | 0 | 5 | 5 |
| 2019 9 | 0 | 17 | 17 |
| 2019 8 | 0 | 6 | 6 |
| 2019 7 | 0 | 11 | 11 |
| 2019 6 | 0 | 7 | 7 |
| 2019 5 | 0 | 51 | 51 |
| 2019 4 | 0 | 25 | 25 |
| 2019 3 | 1 | 6 | 7 |
| 2019 2 | 1 | 7 | 8 |
| 2019 1 | 1 | 1 | 2 |
| 2018 12 | 1 | 4 | 5 |
| 2018 11 | 11 | 7 | 18 |
| 2018 10 | 9 | 0 | 9 |
| 2018 9 | 1 | 0 | 1 |
| 2018 5 | 0 | 1 | 1 |
| 2018 4 | 0 | 2 | 2 |
| 2018 3 | 3 | 2 | 5 |
| 2018 2 | 17 | 12 | 29 |
| 2018 1 | 18 | 12 | 30 |
| 2017 12 | 25 | 9 | 34 |
| 2017 11 | 22 | 4 | 26 |
| 2017 10 | 25 | 5 | 30 |
| 2017 9 | 25 | 13 | 38 |
| 2017 8 | 23 | 15 | 38 |
| 2017 7 | 19 | 9 | 28 |
| 2017 6 | 34 | 14 | 48 |
| 2017 5 | 23 | 11 | 34 |
| 2017 4 | 34 | 4 | 38 |
| 2017 3 | 27 | 24 | 51 |
| 2017 2 | 24 | 10 | 34 |
| 2017 1 | 29 | 5 | 34 |
| 2016 12 | 52 | 12 | 64 |
| 2016 11 | 40 | 6 | 46 |
| 2016 10 | 32 | 20 | 52 |
| 2016 9 | 43 | 9 | 52 |
| 2016 8 | 64 | 7 | 71 |
| 2016 7 | 38 | 8 | 46 |
| 2016 6 | 12 | 7 | 19 |
| 2016 5 | 7 | 5 | 12 |
| 2016 4 | 5 | 25 | 30 |
| 2016 3 | 18 | 1 | 19 |
| 2016 2 | 14 | 9 | 23 |
| 2016 1 | 13 | 11 | 24 |
| 2015 12 | 17 | 2 | 19 |
| 2015 11 | 17 | 11 | 28 |
| 2015 10 | 7 | 9 | 16 |
| 2015 9 | 9 | 7 | 16 |
| 2015 8 | 14 | 1 | 15 |
| 2015 7 | 49 | 7 | 56 |
| 2015 6 | 34 | 8 | 42 |
| 2015 5 | 89 | 13 | 102 |
| 2015 4 | 55 | 21 | 76 |
| 2015 3 | 47 | 24 | 71 |
| 2015 2 | 36 | 18 | 54 |
| 2015 1 | 38 | 16 | 54 |
| 2014 12 | 37 | 10 | 47 |
| 2014 11 | 16 | 11 | 27 |
| 2014 10 | 38 | 18 | 56 |
| 2014 9 | 26 | 17 | 43 |
| 2014 8 | 41 | 12 | 53 |
| 2014 7 | 51 | 17 | 68 |
| 2014 6 | 40 | 13 | 53 |
| 2014 5 | 50 | 19 | 69 |
| 2014 4 | 59 | 14 | 73 |
| 2014 3 | 55 | 26 | 81 |
| 2014 2 | 47 | 13 | 60 |
| 2014 1 | 51 | 19 | 70 |
| 2013 12 | 36 | 18 | 54 |
| 2013 11 | 31 | 27 | 58 |
| 2013 10 | 33 | 28 | 61 |
| 2013 9 | 32 | 20 | 52 |
| 2013 8 | 18 | 25 | 43 |
| 2013 7 | 30 | 30 | 60 |
| 2013 6 | 22 | 20 | 42 |
| 2013 5 | 18 | 22 | 40 |
| 2013 4 | 22 | 33 | 55 |
| 2013 3 | 27 | 41 | 68 |
| 2013 2 | 17 | 18 | 35 |
Show all
